Fuso Pharmaceutical Industries Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fuso Pharmaceutical Industries Ltd with three other
companies in this sector in Japan:
Nippon Chemiphar Co., Ltd.
sales of 35.60 billion Japanese Yen [US$342.85 million]
of which 97%
was Pharmaceutical Business),
Eiken Chemical Co., Ltd.
(32.16 billion Japanese Yen [US$309.73 million]
of which 56%
was Immunoserology Test Agent), and
Aska Pharmaceutical Company Limited
(43.22 billion Japanese Yen [US$416.16 million]
of which 90%
was Pharmaceutical Products Business).
During the year ended March of 2016, sales at
Fuso Pharmaceutical Industries Ltd were ¥45.75 billion (US$440.59 million).
decrease of 2.7%
versus 2015, when the company's sales were ¥47.04 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Fuso Pharmaceutical Industries Ltd had sales
of ¥47.47 billion.